Company
Mission
Scipher Medicine is a precision immunology company on a mission to match each patient with their most effective therapy and bring forward the day when every autoimmune disease patient reaches remission, and no one suffers in silence.
Our Story
Over the past two decades, research into the human genome and the rise of artificial intelligence have opened the door to transform the diagnosis and treatment of autoimmune disease.
Our founders, Drs. Joseph Loscalzo and Laszlo Barabasi set on a path of mapping human disease biology.
Scipher Medicine is Founded.
The map covers 89% of all proteins in human cells, revealing the underlying causes of some of the most difficult diseases.
Scipher closes Series A funding | Completed observational study for anti-TNF response test in rheumatoid arthritis
Scipher closes Series B funding | United Health Group invests in Scipher
PrismRA launches commercially | Scipher and Galapagos sign collaboration in inflammatory bowel disease
Scipher closes Series C financing | PrismRA launches among the TNF-exposed population
Scipher closes Series D funding | Scipher publishes 3 new studies on the clinical utility of PrismRA | Galapagos in-licenses novel drug targets
PrismRA receives Medicare coverage | Scipher signs multi-target partnership with Ionis
PrismRA test available in Quest labs across the U.S.
Our founders, Drs. Joseph Loscalzo and Laszlo Barabasi set on a path of mapping human disease biology.
Scipher Medicine is Founded.
The map covers 89% of all proteins in human cells, revealing the underlying causes of some of the most difficult diseases.
Scipher closes Series A funding | Completed observational study for anti-TNF response test in rheumatoid arthritis
Scipher closes Series B funding | United Health Group invests in Scipher
PrismRA launches commercially | Scipher and Galapagos sign collaboration in inflammatory bowel disease
Scipher closes Series C financing | PrismRA launches among the TNF-exposed population
Scipher closes Series D funding | Scipher publishes 3 new studies on the clinical utility of PrismRA | Galapagos in-licenses novel drug targets
PrismRA receives Medicare coverage | Scipher signs multi-target partnership with Ionis
PrismRA test available in Quest labs across the U.S.
Scipher Team
Leadership
-
CLICK FOR BIOMichael King, MBAChief Financial Officer
Board of Directors
-
CLICK FOR BIOTimothy AndersonManaging Director, Blue Owl
-
CLICK FOR BIOAlbert-László Barabási, PhDFounder | Professor, Harvard and Northeastern University
-
CLICK FOR BIOSamir KaulFounding Partner and Managing Director, Khosla Ventures
-
CLICK FOR BIOMiklos KoborFounder and CEO, Central European Private Equity Investments
-
CLICK FOR BIOJoseph Loscalzo, PhD, MDFounder | Physician-in-Chief, Brigham and Women’s Hospital
-
CLICK FOR BIOGlenn P Muir, MBA, MScChair of Audit Committee
-
CLICK FOR BIOTodd Sone, MBAGeneral Partner, aMoon
Other Team Members
Commercial
Business Development
Medical Affairs
Data Science
General Administration
-
CLICK FOR BIOCourtney MorrisSenior Director, Value & Data Analytics
-
CLICK FOR BIOStacey KaufmanSr. Director, Quality
-
CLICK FOR BIOEmily KerwinController
-
CLICK FOR BIOPauline CallinanBusiness Development
Join Us. Make an Impact.
Learn more about the values that we live each day to drive our mission forward and how you can make an impact by working at Scipher.